612 related articles for article (PubMed ID: 27645291)
1. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer's Disease.
Latina V; Giacovazzo G; Cordella F; Balzamino BO; Micera A; Varano M; Marchetti C; Malerba F; Florio R; Ercole BB; La Regina F; Atlante A; Coccurello R; Di Angelantonio S; Calissano P; Amadoro G
Acta Neuropathol Commun; 2021 Mar; 9(1):38. PubMed ID: 33750467
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's Retinopathy: Seeing Disease in the Eyes.
Mirzaei N; Shi H; Oviatt M; Doustar J; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurosci; 2020; 14():921. PubMed ID: 33041751
[TBL] [Abstract][Full Text] [Related]
5. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.
Liu B; Rasool S; Yang Z; Glabe CG; Schreiber SS; Ge J; Tan Z
Am J Pathol; 2009 Nov; 175(5):2099-110. PubMed ID: 19834067
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.
Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S
Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901
[TBL] [Abstract][Full Text] [Related]
8. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye.
Lee S; Jiang K; McIlmoyle B; To E; Xu QA; Hirsch-Reinshagen V; Mackenzie IR; Hsiung GR; Eadie BD; Sarunic MV; Beg MF; Cui JZ; Matsubara JA
Front Neurosci; 2020; 14():758. PubMed ID: 32848548
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
[TBL] [Abstract][Full Text] [Related]
11. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
Schultz N; Byman E; ; Wennström M
J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
[TBL] [Abstract][Full Text] [Related]
12. Retinal Vasculopathy in Alzheimer's Disease.
Shi H; Koronyo Y; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Mirzaei N; Koronyo-Hamaoui M
Front Neurosci; 2021; 15():731614. PubMed ID: 34630020
[TBL] [Abstract][Full Text] [Related]
13. Retinal pathological features and proteome signatures of Alzheimer's disease.
Koronyo Y; Rentsendorj A; Mirzaei N; Regis GC; Sheyn J; Shi H; Barron E; Cook-Wiens G; Rodriguez AR; Medeiros R; Paulo JA; Gupta VB; Kramerov AA; Ljubimov AV; Van Eyk JE; Graham SL; Gupta VK; Ringman JM; Hinton DR; Miller CA; Black KL; Cattaneo A; Meli G; Mirzaei M; Fuchs DT; Koronyo-Hamaoui M
Acta Neuropathol; 2023 Apr; 145(4):409-438. PubMed ID: 36773106
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.
Koronyo Y; Salumbides BC; Black KL; Koronyo-Hamaoui M
Neurodegener Dis; 2012; 10(1-4):285-93. PubMed ID: 22343730
[TBL] [Abstract][Full Text] [Related]
16. Retinal Changes in Transgenic Mouse Models of Alzheimer's Disease.
Guo L; Ravindran N; Shamsher E; Hill D; Cordeiro MF
Curr Alzheimer Res; 2021; 18(2):89-102. PubMed ID: 33855942
[TBL] [Abstract][Full Text] [Related]
17. Retinal Degeneration and Alzheimer's Disease: An Evolving Link.
Ashok A; Singh N; Chaudhary S; Bellamkonda V; Kritikos AE; Wise AS; Rana N; McDonald D; Ayyagari R
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023198
[TBL] [Abstract][Full Text] [Related]
18. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
Huber CM; Yee C; May T; Dhanala A; Mitchell CS
J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
[TBL] [Abstract][Full Text] [Related]
19. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurol; 2017; 8():701. PubMed ID: 29312125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
